資料搜尋諮詢服務
找不到您所需要的資料嗎?
我們能協助您找到最符合您研究需求的資訊
請撥打 +886-2-2799-3110
或透過電子郵件與我們聯絡 mi@hintoninfo.com
IHS_EWBIEEE xploreSTRATEGY ANALYTICSIHS_EWB_GF

Oligonucleotide Synthesis Market by Product & Services (Equipment, Reagent, Primer, Probe, Custom Oligos), End-User (Research, Pharmaceutical & Biotechnology), Application (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, RNAi) - Global Forecast to 2019

  • LinkedIn
  • facebook
  • Twitter
出 版 商:MarketsandMarkets
出版日期:2014/08/30
頁  數:176頁
文件格式:PDF
價  格:
USD 4,650 (Single-User License)
USD 5,650 (Multi-User License)
USD 9,000 (Global-User License)
線上訂購或諮詢
The global oligonucleotide synthesis market is expected to reach $1,712.1 million by 2019 from $1,070.7 million in 2014, growing at a CAGR of 9.8% from 2014 to 2019. The global oligonucleotide synthesis market is categorized on the basis of products and services, applications, end users, and geography. The synthesized oligonucleotides segment is expected to register the highest growth rate in the oligonucleotide synthesis market during the forecast period, owing to an increasing number of applications for synthesized oligonucleotides in research, diagnostics and therapeutics; and a growing demand for custom oligos.

Major factors contributing to growth of the oligonucleotide synthesis market include growing R&D expenditure in pharmaceutical and biotech companies; emerging applications of oligos in molecular diagnostics and synthetic biology; and evolving significance of RNA-interference oligos in therapeutics and diagnostics. Furthermore, government support and venture capital funding are other major factors that will boost the growth of this market. For instance, the U.S. National Institutes of Health (NIH) spend $1.5 billion per year to support their oligonucleotide-based applications. Further, in January 2013, Solstice Biologics, a South California start-up, raised $18 million in a series-A financing backed by venture capital funding for targeting and delivery of nucleic acid therapeutics. The relatively-untapped markets of the Asia-Pacific (APAC) region and the increasing R&D activities and funding there have opened up an array of opportunities for the oligonucleotide synthesis market. However, factors such as regulatory barriers, especially for therapeutic oligos, and downward pricing pressure may restrain the growth of this market.

Apart from the comprehensive geographic and product analysis, and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by players in the industry over the last three years. In addition, the company profiles comprise the key players in the oligonucleotide synthesis market and their product portfolios, developments, and strategies. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output, in order to remain successful.

Reasons to Buy the Report:

The report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms garner a greater market share. Firms purchasing the report can use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

‧ Market Penetration: Comprehensive information on product portfolios of the top players in the oligonucleotide synthesis market. The report analyzes the oligonucleotide synthesis market by products and services, applications, end users, and geography
‧ Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the oligonucleotide synthesis market
‧ Competitive Assessment: In-depth assessment of the market strategies, geographical and business segments, and product portfolios of the leading players in the oligonucleotide synthesis market
‧ Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the market for various oligonucleotide synthesis products across geographies
‧ Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the oligonucleotide synthesis market
TABLE OF CONTENTS

1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKETS COVERED 17
1.3 STAKEHOLDERS 18
1.4 MARKET SCOPE 19
2 RESEARCH METHODOLOGY 20
2.1 MARKET SIZE ESTIMATION 21
2.2 MARKET CRACKDOWN & DATA TRIANGULATION 23
2.3 KEY DATA FROM SECONDARY SOURCES 23
2.4 KEY DATA FROM PRIMARY SOURCES 24
2.5 KEY INDUSTRY INSIGHTS 25
2.6 ASSUMPTIONS 25
3 EXECUTIVE SUMMARY 26
4 PREMIUM INSIGHTS 29
4.1 ATTRACTIVE MARKET OPPORTUNITIES IN THE SYNTHESIZED OLIGONUCLEOTIDES MARKET 29
4.2 OLIGONUCLEOTIDE SYNTHESIS MARKET IN THE ASIA-PACIFIC REGION 30
4.3 U.S. COMMANDS NEARLY HALF OF THE MARKET SHARE 31
4.4 GEOGRAPHIC REVIEW OF THE OLIGONUCLEOTIDE SYNTHESIS MARKET 32
4.5 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: PCR SEGMENT (2019) 33
4.6 SIGNIFICANT CONTRIBUTION OF SYNTHESIZED OLIGONUCLEOTIDES TO THE TOTAL MARKET GROWTH FROM 2014–2019 34
4.7 LIFE CYCLE ANALYSIS, BY GEOGRAPHY 35
5 MARKET OVERVIEW 36
5.1 INTRODUCTION 37
5.2 MARKET SEGMENTATION 37
5.2.1 OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCTS & SERVICES 37
5.2.2 OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION 38
5.2.3 OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER 38
5.3 MARKET DYNAMICS 39
5.3.1 DRIVERS 40
5.3.1.1 Increasing R&D expenditure in pharmaceutical and biotechnology companies to boost the synthetic oligonucleotides (oligos) market 40
5.3.1.2 Rising demand from researchers owing to the growing molecular biology field is driving the market growth 40
5.3.1.3 Increasing significance of personalized medicine, companion diagnostics, and molecular diagnostics driving the market growth 40
5.3.1.4 Continuous innovations in genomics technologies & presence of favorable government support to boost market growth 41
5.3.1.5 Increasing demand for synthetic genes is propelling the demand for oligos 41
5.3.2 RESTRAINTS 43
5.3.2.1 Continuous downward price pressure posing as a major market growth barrier 43
5.3.2.2 Regulatory challenges opposing the market growth, especially for therapeutic oligos 43
5.3.3 OPPORTUNITIES 44
5.3.3.1 Asian market presents significant growth opportunities 44
5.3.3.2 Emerging field of NGS to boost demand for NGS-grade oligos 44
5.3.4 CHALLENGES 46
5.3.4.1 Large-scale synthesis of oligonucleotides 46
5.3.4.2 Manufacturing high-quality RNA oligos 46
5.4 LEADING MARKET PLAYERS 47
5.4.1 EQUIPMENT MARKET 47
5.4.2 REAGENTS MARKET 47
5.4.3 SYNTHESIZED OLIGONUCLEOTIDES MARKET 48
6 INDUSTRY TRENDS 50
6.1 INTRODUCTION 50
6.1.1 INDUSTRY TRENDS 50
6.2 PORTER’S FIVE FORCES ANALYSIS 51
6.2.1 THREAT FROM NEW ENTRANTS 52
6.2.2 THREAT FROM SUBSTITUTES 52
6.2.3 BARGAINING POWER OF SUPPLIERS 52
6.2.4 BARGAINING POWER OF BUYERS 52
6.2.5 INTENSITY OF COMPETITIVE RIVALRY 53
6.3 PEST ANALYSIS 53
6.3.1 POLITICAL FACTORS 54
6.3.2 ECONOMIC FACTORS 54
6.3.3 SOCIAL FACTORS 54
6.3.4 TECHNOLOGICAL FACTORS 55
6.4 SUPPLY CHAIN ANALYSIS 55
6.4.1 KEY INFLUENCERS 56
7 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCTS & SERVICES 57
7.1 INTRODUCTION 58
7.2 SYNTHESIZED OLIGONUCLEOTIDES 60
7.2.1 SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY PRODUCT 61
7.2.1.1 Primers 62
7.2.1.2 Probes 63
7.2.1.3 Large-scale Synthesis Oligos 64
7.2.1.4 Intermediate-scale Synthesis Oligos 65
7.2.2 SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY SERVICE 66
7.2.2.1 Custom Oligos 67
7.2.2.2 Predesigned Oligos 68
7.3 REAGENTS 69
7.4 EQUIPMENT 71
8 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION 74
8.1 INTRODUCTION 75
8.2 RESEARCH 76
8.2.1 PCR 78
8.2.2 QPCR 79
8.2.3 SEQUENCING 80
8.2.4 GENE SYNTHESIS 81
8.2.5 OTHER RESEARCH APPLICATIONS 83
8.3 DIAGNOSTICS 84
8.4 THERAPEUTICS 85
8.4.1 DNA/ANTISENSE OLIGOS 87
8.4.2 RNAI 88
8.4.3 NUCLEIC ACID APTAMERS 89
8.4.4 OTHER THERAPEUTIC APPLICATIONS 89
9 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER 91
9.1 INTRODUCTION 92
9.2 ACADEMIC RESEARCH INSTITUTES 93
9.3 DIAGNOSTIC LABORATORIES 95
9.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 96
9.5 OTHERS 97
10 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY GEOGRAPHY 98
10.1 INTRODUCTION 99
10.2 NORTH AMERICA 100
10.2.1 U.S. 105
10.2.2 CANADA 106
10.3 EUROPE 107
10.4 ASIA-PACIFIC (APAC) 110
10.5 LATIN AMERICA 116
10.6 MIDDLE EAST & AFRICA 119
11 COMPETITIVE LANDSCAPE 123
11.1 OVERVIEW 123
11.2 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, CONTRACTS, & JOINT VENTURES 126
11.3 EXPANSIONS 127
11.4 NEW PRODUCT LAUNCHES 128
11.5 MERGERS & ACQUISITIONS 129
11.6 OTHER DEVELOPMENTS 130
12 COMPANY PROFILES 131
12.1 BIOAUTOMATION CORPORATION 131
12.2 GE HEALTHCARE (A SUBSIDIARY OF GENERAL ELECTRIC COMPANY) 134
12.3 INTEGRATED DNA TECHNOLOGIES 137
12.4 SIGMA-ALDRICH CORPORATION 142
12.5 THERMO FISHER SCIENTIFIC, INC. 148
12.6 BIOSEARCH TECHNOLOGIES, INC. 154
12.7 EUROFINS GENOMICS (A SUBSIDIARY OF EUROFINS SCIENTIFIC GROUP) 158
12.8 EUROGENTEC (A SUBSIDIARY OF KANEKA CORPORATION) 161
12.9 GENEDESIGN, INC. 164
12.10 TRILINK BIOTECHNOLOGIES, INC. 166
*Details on Business Overview, Financial, Product Portfolio, Key Strategy, & Recent Developments might not be captured in case of unlisted companies.
13 APPENDIX 169
13.1 DISCUSSION GUIDE 169
13.2 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 172
13.3 AVAILABLE CUSTOMIZATIONS 173
13.4 RELATED REPORTS 174
回上頁